Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Joi A. Gleason"'
Autor:
Rosalynn Gill, Briana E. Jones, Kepra Jack, Michael L. Dansinger, Harold Robert Superko, Paul T. Williams, Debanjali Ghosh, Joi A. Gleason, Steve Richards, Megan McCarthy
Publikováno v:
Journal of Occupational & Environmental Medicine. 61:183-189
Objective We tested the hypothesis that a lifestyle program would improve risk factors linked to cardiovascular disease (CVD) in first responders. Methods A 1-year cluster-randomized controlled clinical trial in 10 cities. Participants were 175 first
Autor:
Katalin V. Horvath, Reyhan Gedik, Joi A. Gleason, Ivor B. Asztalos, Bela F. Asztalos, Stefania Lamon-Fava, Sakine Sever, Ernst J. Schaefer, Michael L. Dansinger
Publikováno v:
Metabolism. 65:1636-1645
Background Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the primary omega-3 fatty acids in fish oil, have been shown to reduce cardiovascular disease (CVD) risk. Objective This study aimed to examine the independent effects of EPA and
Autor:
Sai Krupa Das, Paul J. Fuss, J. Philip Karl, Ernst J. Schaefer, Edward Saltzman, Joi A. Gleason, Helen Rasmussen, Susan B. Roberts
Publikováno v:
Obesity. 23:2190-2198
Objective To examine the effects of diets varying in carbohydrate and glycemic index (GI) on changes in body composition, resting metabolic rate (RMR), and metabolic adaptation during and after weight loss. Methods Adults with obesity (n = 91) were r
Autor:
Paul T. Williams, H. Robert Superko, Jack Kepra, Briana E. Jones, Michael L. Dansinger, Debanjali Ghosh, Rosalynn Gill, Joi A. Gleason, Megan McCarthy
Publikováno v:
Journal of the American College of Cardiology. 71:A1853
Publikováno v:
The Journal of Nutrition. 139:1257S-1262S
Absorbed glucose and fructose differ in that glucose largely escapes first-pass removal by the liver, whereas fructose does not, resulting in different metabolic effects of these 2 monosaccharides. In short-term controlled feeding studies, dietary fr
Publikováno v:
Journal of the American Dietetic Association. 102:1445-1451
Lack of adherence to diet contributes to ineffective dietary responsiveness and elevated cardiovascular risk factors in coronary heart disease (CHD) patients. Our purpose was to determine if home-delivered, heart-healthy meals and snacks, combined wi
Autor:
Katalin V. Horvath, Michael L. Dansinger, Ivor B. Asztalos, Joi A. Gleason, Peter J. Gillies, Ernst J. Schaefer
Publikováno v:
The FASEB Journal. 24
Publikováno v:
Current atherosclerosis reports. 7(6)
Although there is consensus about restriction of dietary saturated and trans fatty acids, cholesterol, and sugars, there is debate about what the optimal total fat and carbohydrate content of the diet should be for weight loss and coronary heart dise
Autor:
Timothy Tayler, Joi L. Gleason, Andrea Ferrari, Joel J. Rubenstein, Jennifer A Daly, Judith R. McNamara, Ernst J. Schaefer, Bela F. Asztalos, Leo J. Seman
Publikováno v:
The American journal of cardiology. 95(9)
The effects of atorvastatin (40 mg/day) versus placebo on fasting and postprandial plasma levels of high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A2 (Lp-PLA2) were examined over 36 weeks in 84 patients who had
Autor:
Jennifer A Daly, Joi L. Gleason, Joel J. Rubenstein, Timothy Tayler, Andrea Ferrari, Ernst J. Schaefer, Leo J. Seman, Judith R. McNamara
Publikováno v:
The American journal of cardiology. 93(1)
The effects of atorvastatin at 20, 40, and 80 mg/day on plasma lipoprotein subspecies were examined in a randomized, placebo-controlled fashion over 36 weeks in 97 patients with coronary heart disease (CHD) with low-density lipoprotein (LDL) choleste